Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2

This publication has 26 references indexed in Scilit:

• Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
  British Journal of Cancer, 1999
• Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
  Breast Cancer Research and Treatment, 1992
• Humanization of an anti-p185HER2 antibody for human cancer therapy.
  Proceedings of the National Academy of Sciences, 1992
• Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
  1991
• HORMONAL MODULATION OF HER-2/NEU PROTOONCOGENE MESSENGER-RIBONUCLEIC-ACID AND P185 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES
  1990
• EXPRESSION OF C-ERBB-2 ONCOPROTEIN - A PROGNOSTIC INDICATOR IN HUMAN-BREAST CANCER
  1989
• The neu (c-erbB-2) oncogene.
  1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.
  Molecular and Cellular Biology, 1986
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
  Nature, 1984